Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-28

Clinical Trial Update: Compare Efficacy and Safety of Telmisartan/Hydrochlorothiazide With Telmisartan/Hydrochlorothiazide Plus Amlodipine [Phase 3]

View source ↗

Summary

Phase 3 trial comparing efficacy and safety of Telmisartan/Hydrochlorothiazide alone versus Telmisartan/Hydrochlorothiazide plus amlodipine in hypertension; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine (amlodipine)
  • HYDROCHLOROTHIAZIDE (hydrochlorothiazide)
  • Telmisartan (Telmisartan)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2016-03-28